Parola D et al. |
[Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia]. |
2000 |
Recenti Prog Med |
pmid:10705778
|
Fonquernie L et al. |
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment]. |
2000 |
Presse Med |
pmid:10705894
|
Luman W et al. |
One week triple therapy for Helicobacter pylori associated duodenal ulcer disease. |
1999 |
Singapore Med J |
pmid:10709423
|
Coelho LG et al. |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients. |
2000 |
Am. J. Gastroenterol. |
pmid:10710099
|
Pilotto A et al. |
In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin. |
2000 |
Am. J. Gastroenterol. |
pmid:10710100
|
Kearney DJ and Brousal A |
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. |
2000 |
Dig. Dis. Sci. |
pmid:10711436
|
Lõivukene K et al. |
Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. |
2000 |
Scand. J. Infect. Dis. |
pmid:10716079
|
Edlund C et al. |
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. |
2000 |
Scand. J. Infect. Dis. |
pmid:10716083
|
Ani AE et al. |
Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria. |
1999 Nov-Dec |
Trans. R. Soc. Trop. Med. Hyg. |
pmid:10717760
|
Tran JQ et al. |
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables. |
2000 |
J. Antimicrob. Chemother. |
pmid:10719007
|
Brophy DF et al. |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10722500
|
Numazaki K et al. |
Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10724028
|
Gomollón F et al. |
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain]. |
2000 |
Gastroenterol Hepatol |
pmid:10726384
|
Telenti A and Iseman M |
Drug-resistant tuberculosis: what do we do now? |
2000 |
Drugs |
pmid:10730543
|
Lehmann FS et al. |
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735923
|
Miwa H et al. |
Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735925
|
Spinzi GC et al. |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735926
|
Blackington E |
The gastric demon. An update on Helicobacter pylori infection. |
1999 |
Adv Nurse Pract |
pmid:10745720
|
Paton R et al. |
Susceptibility testing of Haemophilus influenzae to clarithromycin. |
2000 |
J. Antimicrob. Chemother. |
pmid:10747833
|
Shashidhar H et al. |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10749411
|